NCT02400320

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

Cumulative Skin Irritation Study Evaluating the Skin Irritancy Potential of Topical Analgesic Vovilup Spray Containing a Combination of Diclofenac, Menthol, Methyl Salicylate and Linseed Oil and Comparing it With a Marketed Formulation - Iodex Ultragel

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine local skin safety of a topical analgesic spray containing a combination of diclofenac, methyl salicylate, menthol and compare it with a topical analgesic gel containing a combination of diclofenac, methyl salicylate, and menthol.

Conditions

• Skin Irritation

Interventions

Type	Name	Description
DRUG	Topical Spray	Topical spray containing Diclofenac 1.16%, Linseed Oil 3%, Menthol 5%, Methyl salicylate 10%.
DRUG	Topical Gel	Topical gel containing Diclofenac 1.16%, Menthol 5%, Methyl salicylate 10%
OTHER	Saline	Saline

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-06-01
• Completion: 2016-06-30
• First posted: 2015-03-27
• Last updated: 2017-09-12